Analyst Ratings for Cepheid (CPHD) [Buys]
CPHD Rating Summary
CPHD Price Target Summary
- Highest: $50.00 (Canaccord Genuity)
- Lowest: $32.00 (Goldman Sachs)
- Average: $39.82
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$39.82 (+21%)
Avg. $ Target:
$39.82 (+21%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/17/2012 | BofA/Merrill Lynch | New Coverage | Buy (N/A) |
40.00 (N/A) |
32.63 | 32.90 | 0.83% | Details |
| 11/16/2012 | Mizuho Securities | Upgrade | Buy (Neutral) |
N/A (N/A) |
29.42 | 32.90 | 11.83% | Details |
| 10/2/2012 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
34.48 | 32.90 | -4.58% | Details |
| 9/26/2012 | JPMorgan | New Coverage | Overweight (N/A) |
47.00 (N/A) |
38.95 | 32.90 | -15.53% | Details |
| 5/15/2012 | UBS » Updated 4/19/2013 |
Upgrade | Buy (N/A) |
42.00 (40.00) |
37.24 | 32.90 | -11.65% | Details |
| 1/27/2012 | Raymond James | Upgrade | Outperform (N/A) |
N/A (N/A) |
40.80 | 32.90 | -19.36% | Details |
| 1/6/2012 | RBC Capital | Upgrade | Outperform (N/A) |
42.00 (N/A) |
34.28 | 32.90 | -4.03% | Details |
| 7/22/2011 | Natixis Bleichroeder | Upgrade | Buy (N/A) |
40.00 (N/A) |
36.35 | 32.90 | -9.49% | Details |
| 7/22/2011 | Wedbush » Updated 8/30/2011 |
Upgrade | Outperform (N/A) |
45.00 (N/A) |
36.35 | 32.90 | -9.49% | Details |
| 3/17/2011 | Oppenheimer | New Coverage | Outperform (N/A) |
N/A (N/A) |
25.27 | 32.90 | 30.19% | Details |
| 11/16/2010 | Canaccord Genuity » Updated 7/12/2012 |
New Coverage | Buy (N/A) |
50.00 (N/A) |
20.50 | 32.90 | 60.49% | Details |
